Working… Menu
Trial record 81 of 433 for:    OTITIS

Efficacy of KNT® (KINETUBE) in Recurrent Chronic Otitis Media in Children (KINETUBE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02038400
Recruitment Status : Unknown
Verified March 2013 by Assistance Publique Hopitaux De Marseille.
Recruitment status was:  Active, not recruiting
First Posted : January 16, 2014
Last Update Posted : January 16, 2014
Information provided by (Responsible Party):
Assistance Publique Hopitaux De Marseille

Brief Summary:

Otitis media are the consequence of bacterial infection. They are characterized by middle ear inflammations with a collection of fluid behind the eardrum. The effusion stagnates in the middle ear, can increase acute infection and induce tympanic membrane and inner ear damages. Delay in language learning can be observed in affected children as well as hearing problems e.g. constant hearing loss. The two main forms of chronic otitis are otitis media with effusion (OME) and atelectasis with or without retraction pockets.

To date, insertion of tympanic ventilation tubes (tympanostomy) is the most effective treatment for otitis media with effusion that has failed to respond to conservative drug treatments; and for delaying the progression of serious atelectasis. When a first tube did not allow complete recovery, recurrence is then observed and insertion of new tube is needed. The repeated tube insertions increase risks linked to general anesthesia and increase rate of sequelae/complications, such as tympanic membrane perforation.

Kinetube® is a CE-marked medical device, marketed in France and Europe since April 2002. This device improves the neuronal control mechanism of the pharyngotympanic (Eustachian) tube, regulating middle ear pressure. This could be an alternative for patients having recurrence and needing repeated tube insertion, as studies had shown that Kinetube® improved the opening of the Eustachian tube in patients with otitis media with effusion (OME) and atelectasis.

These previous clinical studies have shown the feasibility of the use of Kinetube® in clinical practice. A larger clinical study with a high level of evidence must be performed to show therapeutic efficacy of the Kinetube® in chronic otitis compared to ventilation tube insertion.

Condition or disease Intervention/treatment Phase
Chronic Otitis Infections in pédiatric Patients Device: KINETUBE medical Device Device: insertion of tympanic ventilation tubes (tympanostomy) Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 140 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of the Efficiency of KINETUBE® in the Recurrent Chronic Tubal Ear Otitis Care (Otitis Media With Effusion, Atelectatic Otitis or Retraction) in Children With an Age Range of 7-15 Years.
Study Start Date : November 2013
Estimated Primary Completion Date : July 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ear Infections

Arm Intervention/treatment
Experimental: group A
KINETUBE medical Device
Device: insertion of tympanic ventilation tubes (tympanostomy)
Active Comparator: group B
insertion of tympanic ventilation tubes (tympanostomy)
Device: KINETUBE medical Device

Primary Outcome Measures :
  1. Difference of the deficiency of hearing [ Time Frame: 3 years ]
    Difference of the deficiency of hearing(audition) in decibels HL ( Hearing Level), measured by examination of tonal audiometry (average of the losses in air conductions with the frequencies 500-1000-2000 Hz), between the inclusion and 12 months after the implementation of the treatment(processing)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   7 Years to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients from 7 to 15 years old
  • Patients presenting recurrent otitis media with effusion, or atelectasis (with or without retraction pocket), with presence of fluid behind the eardrum, and conductive hearing loss ≥ 30 dB
  • Patients who had undergone one (or more) previous tympanoplasty tube insertion, and who need a new one
  • Patients whose parents (or parental authority holders) have given voluntary signed informed consent
  • Patients affiliated to the French health insurance system or similar

Exclusion Criteria:

  • Age less than 7 years old and higher than 15 years old
  • Patients needing tympanoplasty tube insertion for the first time
  • Patients who had already received Kinetube® treatment
  • Patients presenting purulent acute otitis media
  • Patients presenting otitis media with effusion following barotrauma
  • Patients presenting neck dysfunction (cleft lip and cleft palate)
  • Patients presenting nasopharynx and nasal cavities tumoral process (except adenoids)
  • Patients with a narrow ear canal that does not allow tympanometry exam
  • Patients with a history of irradiation of the ear, nose and throat
  • Patient who underwent a previous surgery of the soft palate, or with paralysis of the soft palate
  • Patients presenting cilia-related disease or chronic immunodeficiency
  • Patients with Down syndrome
  • Patients taking part, or having taken part, into other clinical study for the treatment of chronic otitis media

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02038400

Layout table for location information
Assistance Publique Hopitaux de Marseille
Marseille, France, 13354
Sponsors and Collaborators
Assistance Publique Hopitaux De Marseille
Layout table for investigator information
Study Director: LOIC MONDOLONI Assistance Publique Hopitaux De Marseille

Layout table for additonal information
Responsible Party: Assistance Publique Hopitaux De Marseille Identifier: NCT02038400     History of Changes
Other Study ID Numbers: 2013-A00490-45
2013-17 ( Other Identifier: AP-HM )
First Posted: January 16, 2014    Key Record Dates
Last Update Posted: January 16, 2014
Last Verified: March 2013
Additional relevant MeSH terms:
Layout table for MeSH terms
Otitis Media
Ear Diseases
Otorhinolaryngologic Diseases